| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/21/2008 | US20080200397 dextrorotatory amino acids; vGek with Dval-gly-Dglu-Dlys as a central D-amino acid sequence; protect against amyloid-mediated neurotoxicity; have no similarities to the amino acid sequence in beta -amyloid regardless of the direction in which they are read |
| 08/21/2008 | US20080200396 Peptides or Peptidic Conjugate Derivatives of Msh and the Use Thereof for Cosmetically Fighting Against Canities |
| 08/21/2008 | US20080200395 Treatment of cancer by a combination of non-ionizing radiation and androgen deprivation |
| 08/21/2008 | US20080200394 Treatment of Inflammatory Airway Disease |
| 08/21/2008 | US20080200393 Treat disease associated with substrate-phosphorylation by VEGF receptor, substrate-phosphorylation by PDGF receptor or substrate-phosphorylation by both VEGF and PDGF receptors |
| 08/21/2008 | US20080200392 Methods for Treating Parkinson's Disease |
| 08/21/2008 | US20080200391 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 08/21/2008 | US20080200390 Exendins and Exendin Agonists Modified with Polyamino Acids |
| 08/21/2008 | US20080200389 Rank-ligand-induced sodium/proton antiporter polypeptides |
| 08/21/2008 | US20080200388 Stem cell factor-like proteins and uses thereof |
| 08/21/2008 | US20080200387 Anti-angiogenic protein, composition and use thereof |
| 08/21/2008 | US20080200386 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/21/2008 | US20080200385 Treat urogenital, intestinal tract cancer; diagnosis, discrimination between cancerous and non-cancerous tissue; determine abundance intracellular, extracellular annexin protein from urine samples |
| 08/21/2008 | US20080200384 Quantify expression of gene encoding subtypes 1and 2 glutamate transporter, and epidermal growth factor; quantify protein level; compare to control; polymerase chain reaction using oligonucleotide primers specific to fragment of the EAAT1, EAAT2 or EGF genes; kit, antibody binds antigenic determinants |
| 08/21/2008 | US20080200383 Long-term stability, extended delivery using a suitable reservoir; pumped or metered at a controlled rate; implantable or external pump device, pen style injection device; stable at physiologic temperatures for duration of therapeutic exposure; supply of therapeutically active material for up to 2 years |
| 08/21/2008 | US20080200382 Inhibiting of the proliferation of tumor cells is mediated by upregulation of the activity of p53 |
| 08/21/2008 | US20080200381 Diagnostic assays for detecting, treating bone, cartilage formation, resorption, osteoporosis, bone fractions; determine level of gene expression of CRLF-1 and/or MMP23 in biological sample |
| 08/21/2008 | US20080200380 Compositions For Buccal Delivery Of Parathyroid Hormone |
| 08/21/2008 | US20080200379 Diagnostic markers of human female infertility |
| 08/21/2008 | US20080200378 KGF polypeptide compositions |
| 08/21/2008 | US20080200377 Polyamideesters comprised of dicarboxylic acid and reaction product of diol and amino acid; drug delivery through blood vessels; controlled release, reduced adverse effects, inactivation protection, intracellular penetration enhanced pharmacological activity |
| 08/21/2008 | US20080200376 Compositions and Methods For the Treatment Of Obesity and Sexual Dysfunction |
| 08/21/2008 | US20080200375 Treating vascular insufficiency or limb ischemia secondary to arterial occlusive disease; kits |
| 08/21/2008 | US20080200374 Mutational derivatives of microcin j25 |
| 08/21/2008 | US20080200373 Multi-Component Biological Transport Systems |
| 08/21/2008 | US20080200372 Glycosaminoglycan Peptides Derived From Connective Tissues And Use Thereof In The Prevention Of Arthritis And Other Degenerative Medical Conditions |
| 08/21/2008 | US20080200371 Thiazole and thiadiazole inhibitors of tyrosine phosphatases |
| 08/21/2008 | US20080200370 Method of treating drug addiction using dextro-morphine |
| 08/21/2008 | US20080200369 Inhibiting bystin mediated arrest and promoting autophosphorylation of epidermal growth factor receptor; sperm motility, embryonic stem cell formation, trophoblast formation, neuronal growth |
| 08/21/2008 | US20080200368 Peptide composition |
| 08/21/2008 | US20080200367 Compositions and Methods for Treating Sleep Disorders |
| 08/21/2008 | US20080200366 Modulating melanocortin receptors |
| 08/21/2008 | US20080199940 Cosmids; vectors; prokaryotics; Micromonospora biosynthesis |
| 08/21/2008 | US20080199936 FEN Endonucleases |
| 08/21/2008 | US20080199931 Expression vector comprising estrogen signaling protein (IEBP) for use as tool in diagnosis, prevention and treatment of cell proliferative abd bone disorders |
| 08/21/2008 | US20080199911 Producing water-soluble protein from chimeric water-insoluble via polypeptide refolding; preparing genetic vaccine for treatment and prevention of viral infection in animal; veterinary medicine |
| 08/21/2008 | US20080199885 Using tumor marker (mammaglobin B) profile as diagnostic/prognostic indicator for urogenital cancers in women |
| 08/21/2008 | US20080199860 Variants of the alpha 1 subunit of human ampk |
| 08/21/2008 | US20080199532 Congestive heart failure; induce vasodilation |
| 08/21/2008 | US20080199529 Nanoparticle delivery vehicle |
| 08/21/2008 | US20080199528 Colonic delivery of metallo-dependent enzymes |
| 08/21/2008 | US20080199519 Production of Double-or Multi-Layered Microcapsules |
| 08/21/2008 | US20080199514 Nucleotide polymorphism in gene coding; causing mutants; prevents binding; useful for diagnosis, therapy |
| 08/21/2008 | US20080199509 Preventing, reducting biofilms by administering charged polyamino acid; antiinflammatory agents; respiratory system disorders |
| 08/21/2008 | US20080199508 Containing polyglycan and mucopolysaccharides with polypeptides; improve performance of medical device |
| 08/21/2008 | US20080199503 Mixture of oligopeptide and cyclodextrins; model for drug design ; hypotensive agenst; cardiovascular disorders; atherosclerosis; antitumor agenst; antidiabetic agenst |
| 08/21/2008 | US20080199498 In situ administering Clostridium toxin; antiinflammatory agents |
| 08/21/2008 | US20080199496 Protein disulfide isomerase for therapy, detection, prevention of leishmaniasis; parasiticides |
| 08/21/2008 | US20080199495 Administering hematopoietic stem cells for activation of gland; improve immunology response to leutinizing hormone- releasing hormone; antitumor, anticancwer agents |
| 08/21/2008 | US20080199486 Grp94-based compositions and methods of use thereof |
| 08/21/2008 | US20080199485 Method for enhancing T cell response |
| 08/21/2008 | US20080199483 Long lasting fusion peptide inhibitors of viral infection |
| 08/21/2008 | US20080199479 Method of treating a muscle-related condition with modified IGF1 polypeptides |
| 08/21/2008 | US20080199478 Combinations of Immunosupressive Agents for the Treatment or Prevention of Graft Rejections |
| 08/21/2008 | US20080199477 Human receptor proteins; related reagents and methods |
| 08/21/2008 | US20080199475 Novel glycosylated peptide target in neoplastic cells |
| 08/21/2008 | US20080199473 Novel Gene and Protein Associated With Angiogenesis and Endothelial Cell-Specific Apoptosis |
| 08/21/2008 | US20080199472 Using secretory leukocyte protease inhibitor (SLPI) to identify modulators for treatment and prevention of tumor migration |
| 08/21/2008 | US20080199469 Using A20 binding inhibitor of NF- kappa B (ABIN) to stabilize MEK kinase and treat and/or prevent inflammatory diseases |
| 08/21/2008 | US20080199468 Method For Diagnosing Colorectal Cancers |
| 08/21/2008 | US20080199466 Activation-inducible lymphocyte immunomediatory molecule specific immunoglobulin for treating and preventing inflammatory, autoimmune, ischemic, transplant and/or allergic disorders |
| 08/21/2008 | US20080199465 Accelerated lymphocyte homing agent such as fingolimod and one or more compounds selected from an antibody to the IL-2 receptor, an immunosuppressive macrocyclic lactone and a soluble human complement inhibitor |
| 08/21/2008 | US20080199462 Preventing airway mucus production by administration of egf-r antagonists |
| 08/21/2008 | US20080199458 Therapeutic mixture comprising St. john's wort and preferential immunoglobulins for use in treatment of viral infections |
| 08/21/2008 | US20080199456 Immunogens; vaccines; fusion proteins; antibodies; host cells; diagnostic kits |
| 08/21/2008 | US20080199454 Caspase inhibitor prodrugs |
| 08/21/2008 | US20080199453 Treating cholecystitis with separate mixtures comprising extracellular matrix digesting enzyme and botulinum toxin |
| 08/21/2008 | US20080199452 Botulinum toxin compositions and methods |
| 08/21/2008 | US20080199451 Composition for the Treatment and/or Prevention of Attacks by Biological Agents |
| 08/21/2008 | US20080199450 Acid ceramidase and cell survival |
| 08/21/2008 | US20080199449 Methods and Compositions for Use in Treating Vascular Diseases and Conditions |
| 08/21/2008 | US20080199448 Enzyme composition for improving food digestion |
| 08/21/2008 | US20080199447 Metalloprotease catalytic site for use in identifying modulators for prevention and treatment of respiratory system disorders |
| 08/21/2008 | US20080199443 Bone Morphogenetic Variants, Compositions and Methods of Treatment |
| 08/21/2008 | US20080199442 Gene linked to control elements capable of directing in vivo transcription and translation; systemic delivery of erythropoietin |
| 08/21/2008 | US20080199439 Displaces inhibitor of apoptosis proteins (IAP) from caspase; modification of light emission when bound to cell; selectively damages or kills neoplastic cells |
| 08/21/2008 | US20080199438 Methods For Suppressing Tumor Proliferation |
| 08/21/2008 | US20080199436 Binds to cerebrovascular endothelial cell; expression vectors; micelle, liposome or microcapsule used as carriers |
| 08/21/2008 | US20080199428 Administering deferasirox, 4-(3,5-Bis-(2-hydroxyphenyl)-(1,2,4)-triazol-1-yl)benzoic acid, interferon and ribavirin; hepatitis and non-alcoholic steatohepatitis |
| 08/21/2008 | US20080199427 Reacting 5-(6-chloro-pyridazin-3-ylmethyl)-2-(2-fluoro-phenyl)-5H-imidazo(4,5-c)pyridine with 2,4-bis(trifluromethyl)phenylboronic acid in presence of dimethoxyethane; treatment or prophylaxis of hepatitis C |
| 08/21/2008 | US20080199426 Administering compound which inhibits tie-1 protein, thrombin, growth factors; increases activity of nitric oxide synthase; arteriosclerosis, sepsis, rheumatoid arthritis and pre-eclampsia |
| 08/21/2008 | US20080199425 Administering monophenol or benzenediol compounds which modify tyrosinase proteins; stimulate inflammatory response; 4-tertiary butylphenol, fludarabine and cyclophosphamide |
| 08/21/2008 | US20080199423 Enhancing apoptosis or cytolytic activity using natural killer cells;ligand polypeptide; interleukins, interferons; anticarcinogen |
| 08/21/2008 | US20080199422 Method for the Treatment of Myelodysplastic Syndromes Using 1-Oxo-2-(2,6-Dioxopiperidin-3-Yl-)-4-Methylisoindoline |
| 08/21/2008 | US20080199410 Pulmonary surfactant formulations and methods for promoting mucus clearance |
| 08/21/2008 | US20080199405 Polypeptide comprising a soluble Mycobacterium tuberculosis antigen; vaccines |
| 08/21/2008 | US20080199400 Otologic nanotechnology |
| 08/21/2008 | US20080199398 Polypeptide conjugate comprising helices of ApoA-1 apolipoproteins and peptide linking groups; antiinflammatory domain and/or domain that effects lecithin-cholesterol acyltransferase (LCAT); dyslipidemic disorders, stroke and myocardial infarction; cardiovascular disorders; detecting plaque |
| 08/21/2008 | DE102007008664A1 Mittel zur Anwendung bei Fructoseintoleranz Means for use in fructose intolerance |
| 08/21/2008 | DE102007006663A1 Transport von Arzneistoffen über die Blut-Hirn-Schranke mittels Apolipoproteinen Transport of drugs across the blood-brain barrier by means of apolipoproteins |
| 08/21/2008 | CA2715529A1 Immunotherapy for immune suppressed patients |
| 08/21/2008 | CA2713977A1 Methods and compositions for the disruption of biofilms |
| 08/21/2008 | CA2678468A1 Polypeptide comprising a knottin protein moiety |
| 08/21/2008 | CA2678436A1 Serpine1 polymorphisms are predictive of response to activated protein c administration and risk of death |
| 08/21/2008 | CA2678432A1 Vaccine therapy for choroidal neovascularization |
| 08/21/2008 | CA2678389A1 Wnt3a for inhibition of scarring |
| 08/21/2008 | CA2678387A1 Use of wnt3a for acceleration of wound healing |
| 08/21/2008 | CA2678064A1 Intraperitoneal administration of antithrombin iii, related compositions and methods |
| 08/21/2008 | CA2678001A1 Therapeutic application of kazal-type serine protease inhibitors |
| 08/21/2008 | CA2677948A1 Treatment of trauma-hemorrhage with short oligopeptides |